Spyre Therapeutics, Inc. (SYRE)
109.03
+5.17
(+4.98%)
USD |
NASDAQ |
Nov 09, 16:00
106.85
-2.18
(-2.00%)
After-Hours: 18:05
Spyre Therapeutics Gross Profit (Annual) : 0.00 for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| December 31, 2023 | -0.078M |
| December 31, 2022 | 0.365M |
| December 31, 2021 | 16.74M |
| December 31, 2020 | -1.624M |
| Date | Value |
|---|---|
| December 31, 2019 | -0.901M |
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 5.996M |
| December 31, 2014 | -0.019M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| AbbVie, Inc. | 42.89B |
| Incyte Corp. | 4.703B |
| SELLAS Life Sciences Group, Inc. | 0.00 |
| Relay Therapeutics, Inc. | 11.80M |
| ACADIA Pharmaceuticals, Inc. | 971.62M |